Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.
Minoryx Therapeutics has raised $31.5M in total funding. The most recent round was Grant. The last funding was announced in July 2025.
Minoryx Therapeutics's investors include European Investment Bank, Columbus Venture Partners, Ysios Capital, Inveready, Kurma Partners.
Minoryx Therapeutics is headquartered in Barcelona, Spain.
Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.
Minoryx Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Minoryx Therapeutics — Funding & Investors." VCBacked, July 10, 2025, https://www.vcbacked.co/company/minoryx-therapeutics. Accessed November 12, 2026.
VCBacked. (2025). Minoryx Therapeutics — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/minoryx-therapeutics
{{cite web |title=Minoryx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/minoryx-therapeutics |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Minoryx Therapeutics? Request a listing update